Diabetes Clinical Trials in Florida

Showing 321-340 of 394 trials

Multicenter Worksite Nutrition Study

NCT01224548

The purpose of this study is to study the potential benefits of low fat vegan diet in a randomized, controlled and multi-centered workplace setting, the investigators will enroll participants from 10 worksites of Government Employee Insurance Company (GEICO). After randomization, 5 will be the vegan sites and 5 will be the control sites for 10 month study. The vegan sites will receive low fat vegan diet instructions and weekly group sessions starting from year 1. no intervention is done to the control sites until the week 18 when the identical program will be given. At various time points, health measurements will be give to all participants.

DiabetesOverweight

Physicians Committee for Responsible Medicine292 participantsStarted Oct 2010

Tucson, Arizona, United States • San Diego, California, United States • Lakeland, Florida, United States +7 more locations

WITHDRAWNPhase 349 miles

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

NCT02015780

To evaluate the efficacy of fasiglifam 50 mg once daily compared to placebo on glycemic control as measured by glycosilated haemoglobin (HbA1c) over a 16-week treatment period in participants with Type 2 Diabetes Mellitus (T2DM) and chronic kidney disease (CKD) stage 4 or 5 on dialysis.

Type 2 Diabetes MellitusChronic Kidney Disease

TakedaStarted Dec 2013

Whittier, California, United States • Westminster, Colorado, United States • Tampa, Florida, United States +27 more locations

PreviousPage 17 of 20Next

Multicenter Worksite Nutrition Study

Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis

Diabetes Trials in Other Cities

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Blood Glucose Testing and You

Safety and Efficacy of Once-daily Oral Administrations of TZP-102 for Gastroparesis in Patients With Diabetes Mellitus

Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy

The CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)

A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes

Linagliptin Versus Placebo in Type 2 Diabetic Patients With Inadequate Glycaemic Control on Metformin in Combination With Pioglitazone

Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure

Screening for Early Evidence of Diabetes

Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study

Other Conditions in Florida